Pages that link to "Q38019467"
Jump to navigation
Jump to search
The following pages link to Pioglitazone and vitamin E for nonalcoholic steatohepatitis: a cost utility analysis. (Q38019467):
Displaying 13 items.
- Cost-utility analysis of nonalcoholic steatohepatitis screening. (Q30385602) (← links)
- Controversies in the Diagnosis and Management of NAFLD and NASH. (Q30412296) (← links)
- Cost-effectiveness analysis of ultrasonography screening for nonalcoholic fatty liver disease in metabolic syndrome patients (Q33627037) (← links)
- Screening for Nonalcoholic Steatohepatitis in Individuals with Type 2 Diabetes: A Cost-Effectiveness Analysis. (Q37037308) (← links)
- Pharmacological agents for NASH. (Q38152646) (← links)
- Pharmacological agents for nonalcoholic steatohepatitis. (Q38552387) (← links)
- Therapies for nonalcoholic steatohepatitis (Q38618016) (← links)
- Economic evaluation of a community-based diagnostic pathway to stratify adults for non-alcoholic fatty liver disease: a Markov model informed by a feasibility study (Q38692351) (← links)
- Cost-effectiveness Analysis of Bariatric Surgery for Patients With Nonalcoholic Steatohepatitis Cirrhosis (Q64112452) (← links)
- Bariatric surgery for nonalcoholic steatohepatitis: A clinical and cost-effectiveness analysis (Q88832450) (← links)
- Drug Development for Nonalcoholic Fatty Liver Disease: Landscape and Challenges (Q90086731) (← links)
- Cost-comparison analysis of FIB-4, ELF and fibroscan in community pathways for non-alcoholic fatty liver disease (Q91804048) (← links)
- A Structured Literature Review of the Epidemiology and Disease Burden of Non-Alcoholic Steatohepatitis (NASH) (Q91841255) (← links)